Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participati... von Hüttmann, Andreas, Müller, Stefan P, Rekowski, Jan, Hertenstein, Bernd, Franzius, Christiane, Franzke, Anke, Bengel, Frank M, Kroschinsky, Frank, Kotzerke, Jörg, La Rosée, Paul, Freesmeyer, Martin, Hoeffkes, Heinz-Gert, Hertel, Andreas, Behringer, Dirk, Mesters, Rolf, Weckesser, Matthias, Mahlmann, Stefan, Haberkorn, Uwe, Martens, Uwe, Prange-Krex, Gabriele, Korfel, Agnieszka, Brenner, Winfried, Giagounidis, Aristoteles, Moeller, Regina, Runde, Volker, Sandmann, Matthias, Hautzel, Hubertus, Wilop, Stefan, Krohn, Thomas, Dürk, Heinz, Strumberg, Dirk, Heike, Michael, Ose, Claudia, Brinkmann, Marcus, Trenn, Guido, Kloke, Otto, Kreisel-Büstgens, Christiane, Dang, Tu-Anh, Heil, Gerhard, Jöckel, Karl-Heinz, Hoelzer, Dieter, Klapper, Wolfram, Duehrsen, Ulrich

Volltext

Management of peripheral arterial disease in a patient with myelodysplastic syndrome and severe thrombocytopenia von Stavroulakis, Konstantinos, Mazaris, Savvas, Donas, Konstantinos, Sensebat, Özgün, Karaindros, Konstantinos, Kloke, Otto, Matkares, Joseph, Brinkmann, Jan F

Volltext

Prolonged Administration of Interferon-α in Patients With Chronic-Phase Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Before Allogeneic Bone Marrow Transplantation... von Beelen, Dietrich W., Graeven, Ullrich, Elmaagacli, Ahmet H., Niederle, Norbert, Kloke, Otto, Opalka, Bertram, Schaefer, Ulrich W.

Volltext

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γ von OPALKA, B, WANDL, U. B, BECHER, R, KLOBE, O, NAGEL-HIEMKE, M, MORITZ, T, BEER, U, SEEBER, S, NIEDERLE, N

Volltext

Rapamycin antagonizes interleukin-6 mediated growth arrest and differentiation of myeloblastic M1 cells von Kloke, Otto, Kummer, Gerhard, Seeber, Siegfried

Volltext

Development and mechanisms of interferon resistance von Kloke, Otto, Niederle, Norbert

Volltext

Long-Term Treatment of Chronic Myelogenous Leukemia with Different Interferons: Results from Three Studies von Niederle, Norbert, Kloke, Otto, Wandl, Ursula B., Becher, Reinhard, Moritz, Thomas, Opalka, Bertram

Volltext

Clinical and histological features retain their prognostic impact under interferon therapy of CML: A pilot study von Thiele, Juergen, Kvasnicka, Hans Michael, Niederle, Norbert, Kloke, Otto, Schmidt, Marcus, Lienhard, Heiko, Zirbes, Thomas, Meuter, Raoul Boris, Leder, Lutz Dietrich, Fischer, Robert

Volltext

Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines von Siebert, Reiner, Willers, Christoph P., Fosså, Alexander, Kloke, Otto, Nowrousian, Mohammad R., Seeber, Siegfried, Opalka, Bertram

Volltext

Modulation of the antigraft response by preimmunization: lack of correlation between regulatory events and graft survival von KLOKE, O, KÖLSCH, E

Volltext

Formation of the Early‐Region‐2 Transcription‐Factor‐1‐Retinoblastoma‐Protein (E2F‐1‐RB) TransRepressor and Release of the Retinoblastoma Protein from Nuclear Complexes Containing... von Kirch, Hans‐Christoph, Putzer, Brigitte, Brockmann, Dieter, Esche, Helmut, Kloke, Otto

Volltext

Formation of the Early‐Region‐2 Transcription‐Factor‐1‐Retinoblastoma‐Protein (E2F‐1‐RB) Trans Repressor and Release of the Retinoblastoma Protein from Nuclear Complexes Containing... von Kirch, Hans‐Christoph, Putzer, Brigitte, Brockmann, Dieter, Esche, Helmut, Kloke, Otto

Volltext

Minimal Residual Disease in Patients With Chronic Myelogenous Leukemia Undergoing Long-term Treatment With Recombinant Interferon a-2b Alone or in Combination With Interferon γ von Opalka, Bertram, Wandl, Ursula Brigitte, Becher, Reinhard, Kloke, Otto, Nagel-Hiemke, Marianne, Moritz, Thomas, Beer, Ulrike, Seeber, Siegfried, Niederle, Norbert

Volltext

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma von LINDEMANN, A, HÖFFKEN, K, FRANKS, C. R, HERRMANN, F, MERTELSMANN, R. H, SCHMIDT, R. E, DIEHL, V, KLOKE, O, GAMM, H, HAYUNGS, J, OSTER, W, BÖHM, M, KOLITZ, J. E

Volltext

Tumor necrosis factor α modifies resistance to interferon α in vivo : first clinical data von MORITZ, T, KLOKE, O, NAGEL-HIEMKE, M, KUMMER, G, WANDL, U. B, OPALKA, B, PLAPPERT, B, KEMPENI, J, SEEBER, S, NIEDERLE, N

Volltext

A PvuII Polymorphism of the bcr Region in Patients With Hematopoietic Disorders and Their Families von Opalka, Bertram, Wandl, Ursula, Kloke, Otto, Oberle, Claudia, Koppe, Jutta, Niederle, Norbert, Schmidt, Carl Gottfried

Volltext

A multicenter trial of interleukin-2 and low-dose cyclophosphamide in highly chemotherapy-resistant malignancies von Lindemann, Albrecht, Hoeffken, Klaus, Schmidt, Reinhold E., Diehl, Volker, Kloke, Otto, Gamm, Heinhold, Hayungs, Joerg, Oster, Wolfgang, Boehm, Markus, Franks, Chris R., Herrmann, Friedhelm, Mertelsmann, Roland

Volltext

Evidence for a T suppressor cell‐inducing antigenic determinant shared by ADJ‐PC‐5 plasmacytoma and syngeneic BALB/c spleen cells von Kloke, Otto, Haubeck, Hans‐Dieter, Kölsch, Eckehart

Volltext

Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia von Kloke, Otto, Becher, Reinhard, Niederle, Norbert

Volltext

OPPOSITE SENSITIVITY TO THE ANTIPROLIFERATIVE ACTION OF INTERFERON-ALPHA AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN MONOBLASTIC U937 CELLS von KLOKE, O, MORITZ, T, KUMMER, G, HUST, H, ROSS, B, SEEBER, S, NIEDERLE, N

Volltext